Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/1996
06/06/1996CA2204000A1 Enantioselective preparation of pharmaceutically active sulfoxides by bioreduction
06/06/1996CA2203999A1 Enantioselective preparation of pharmaceutically active sulfoxides by biooxidation
06/05/1996EP0714883A1 Aryloxypropanolamine beta 3 adrenergic agonists
06/05/1996EP0714665A2 Osteogenic devices
06/05/1996EP0714659A2 Indole derivatives in the treatment of emesis
06/05/1996EP0714408A1 Tryptase inhibitor
06/05/1996EP0714404A1 Anti-inflammatory peptides
06/05/1996EP0714389A1 Amide and urea derivatives as 5ht1d receptor antagonists
06/05/1996EP0714294A1 Pharmaceutical compositions comprising metal complexes
06/05/1996CN1123654A Oral compositions
06/04/1996US5523455 Prepared using a naphthylhydrazine chemical intermediate
06/04/1996US5523306 Amino acid derivatives cyclized at the C-terminal
06/04/1996US5523303 Antiulcer and -secretory agents; gastric h+k+ atpase inhibitors; nontoxic; oximes derivatives
06/03/1996CA2164246A1 Aryloxypropanolamine beta 3 adrenergic agonists
05/1996
05/30/1996WO1996016178A1 Immunogens for stimulating mucosal immunity
05/30/1996WO1996016087A1 G-protein coupled receptor
05/30/1996WO1996016075A1 Antibiotic cryptdin peptides and methods of their use
05/30/1996WO1996016065A1 Heterocyclic compounds and their preparation and use
05/30/1996WO1996016060A1 Enterokinetic benzamide
05/30/1996WO1996016053A1 Phthalide compounds and their production process
05/30/1996WO1996016027A1 Matrix metalloprotease inhibitors
05/30/1996WO1996015802A1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
05/30/1996WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers
05/30/1996WO1996015785A1 Freeze-dried ondansetron compositions
05/30/1996WO1996015775A1 Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
05/30/1996CA2205130A1 Immunogens for stimulating mucosal immunity
05/29/1996EP0713864A1 Substituted benzoylguanidines, process for their preparation, their use as medicament of diagnostic agent as well as medicaments containing them
05/29/1996EP0713704A1 2-Amino-1,3-thiazines as nitric oxide synthase inhibitors
05/29/1996EP0713700A1 mUse of lauric acid or a monogryceride of a C8-C16 fatty acid for inhibiting Helicobacter
05/29/1996EP0713698A2 Medical use of atypical beta-adrenoceptor agonists
05/29/1996EP0713529A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-$g(b) FAMILY
05/29/1996EP0713483A1 Amidine derivatives with nitric oxide synthetase activities
05/28/1996US5521315 Olefin substituted long chain compounds
05/28/1996US5521314 N-(3-hydroxy)-4-piperidinyl) (Dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
05/28/1996US5521220 Treating inflammatory and central nervous system disorders
05/28/1996US5521213 Nonsteroid antiinflammatory agents
05/28/1996US5521177 Angiotensin antagonist for cardiovascular disorders such as ischemia or central nervous system disorders such as cognitive functions, depression, alzheimer's disease or parkinson's syndrome
05/28/1996US5521175 Benzodiazepine derivatives
05/28/1996US5521173 Tricyclic benzazepine vasopressin antagonists
05/28/1996US5521170 Benzamide derivatives and pharmaceutical composition comprising the same
05/26/1996CA2163724A1 2-amino-1,3-thiazines as inhibitors of nitric oxide synthase
05/25/1996CA2163598A1 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
05/23/1996WO1996015123A1 Pyridine modulators of acetylcholine receptors
05/23/1996WO1996015109A1 Endothelin antagonists
05/23/1996WO1996015103A1 Diaminocyclobutene-3,4-diones
05/23/1996WO1996014877A1 Novel tumor suppressor gene, hic-1
05/23/1996WO1996014844A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase
05/23/1996CA2205414A1 Novel tumor suppressor gene, hic-1
05/22/1996EP0712926A2 Fish pancreatic disease virus
05/22/1996EP0712837A2 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes
05/22/1996EP0712401A1 Novel dialkoxy-pyridinyl-benzimidazole derivatives
05/22/1996EP0712400A1 Novel substituted benzimidazoles
05/22/1996CN1122711A Hepatitis virus inhibitor and prepn. method thereof
05/22/1996CN1122698A Medicinal powder for poultry
05/22/1996CN1031827C Process for preparation of substituted benzimidazoles
05/21/1996US5519138 Angiotensin antagonist
05/21/1996US5519032 Antidepressants, anxiolytics, antiemetics, antipsychotic
05/21/1996US5519006 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity
05/18/1996CA2160841A1 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
05/17/1996WO1996014317A1 Novel piperidine derivatives with paf antagonist activity
05/17/1996WO1996010639A3 The taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
05/15/1996EP0711299A1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT 3 ANTAGONISTS
05/15/1996EP0711296A1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZOL(5,1-c)(1,4)BENZOXAZIN-1-ONE AND THEIR USE AS THERAPEUTIC AGENTS
05/15/1996EP0711293A1 Imidazolylalkyl derivatives of imidazo(1,5-a)indol-3-one and their use as therapeutic agents
05/15/1996EP0711289A1 Piperazine compounds used in therapy
05/15/1996EP0711284A1 2-benzoheterocyclyloxy or thiopropanolamine derivatives with adreno receptor agonist activity
05/15/1996EP0711283A1 Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists
05/15/1996EP0711282A1 Compounds as pde iv and tnf inhibitors
05/15/1996EP0711281A1 4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonists
05/15/1996EP0711159A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
05/15/1996EP0519983B1 Use of ketorolac for treatment of periodontal disease
05/15/1996CN1122570A Use of granisetron for the treatment of post-operative nausea and vomiting
05/15/1996CN1122338A Physical form of dihydro-2,3-benzodiazepine derivative
05/15/1996CN1122246A Snow Ganoderma lucidum oral liquid
05/15/1996CN1122245A Snow Ganoderma lucidum solid medicament
05/15/1996CN1122228A Chinese herbal medicinal bag for infantile diarrhea and malnutrition
05/14/1996US5516805 Antiischemic agents, anticarcinogenic agents and antiarrhythmia agents for cardiovascular disorders
05/14/1996US5516783 Platelet activating factor
05/14/1996US5516774 Treating diseases characterized by excess renal reabsorption of water
05/14/1996US5516653 Genetic engineering
05/14/1996CA2088273C Processes for formulating a solid oral dosage form of loperamide compounds
05/09/1996WO1996013590A2 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
05/09/1996WO1996013271A1 Compositions and methods for human gastrointestinal health
05/09/1996WO1996013247A1 Antiodor, antimicrobial and preservative compositions and methods of using same
05/09/1996CA2203762A1 Compositions and methods for human gastrointestinal health
05/08/1996EP0710662A1 Quinolinecarboxylic acid derivative
05/08/1996EP0710267A1 Storage stable partially neutralized acid compositions and uses
05/08/1996EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
05/08/1996EP0710230A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
05/08/1996EP0710229A1 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
05/08/1996CN1122109A Veterinary composition containing a proton pump inhibitor
05/08/1996CN1121806A Pharmaceutical agents for treatment of emesis
05/07/1996US5514716 Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
05/07/1996US5514699 Pharmaceutical compounds
05/07/1996US5514663 Laxitive
05/07/1996CA2075551C Treatment of periodontitis
05/07/1996CA1338309C Homologues of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof
05/02/1996WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996WO1996012741A1 Binding agents to cd23
05/02/1996WO1996012716A1 Nucleoside derivatives and process for preparing thereof
1 ... 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 ... 1258